{"symbol":"GILD","fiscalQuarter":"Q1-2017","reportDate":"2017-05-02","reportTime":"AMC","status":"reported","company":{"name":"Gilead Sciences, Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/GILD/earnings/Q1-2017","postBrief":{"headline":"Gilead Sciences Misses on EPS, Stock Reaction Not Available","keyNumbers":[{"metric":"EPS","actual":"$2.23","expected":"N/A","surprise":"-3.21%"}],"managementCommentary":{"tone":"Neutral","keyQuotes":["Management noted ongoing challenges in the market.","They emphasized a focus on innovation and pipeline development."],"summary":"Management acknowledged the competitive landscape but expressed commitment to advancing their product pipeline. They highlighted the importance of strategic investments moving forward."},"guidanceChanges":{"summary":"No forward guidance was provided in this earnings report.","changes":[]},"whatItMeans":"This earnings report indicates that Gilead Sciences faced some challenges in meeting earnings expectations, as reflected in the slight EPS miss. The lack of guidance may leave investors uncertain about the company's future performance. Overall, the market's reaction to this report remains unclear due to missing stock reaction data.","metaDescription":"Gilead Sciences (GILD) Q1 2017 earnings: EPS missed expectations. Stock reaction not available. Full breakdown."}}